Shin Nippon Biomedical Laboratories, Ltd.

  • Market Cap: Small Cap
  • Industry: Miscellaneous
  • ISIN: JP3379950003
JPY
1,952.00
19 (0.98%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
6,477.68
10,178.44
9,726.89
6,958.96
5,549.52
8,465.74
6,100.68
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
6,477.68
10,178.44
9,726.89
6,958.96
5,549.52
8,465.74
6,100.68
Raw Material Cost
3,408.39
4,900.75
4,566.97
3,460.36
2,524.78
3,720.38
2,916.76
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
57.82
54.54
54.21
53.44
40.55
41.92
34.17
Selling and Distribution Expenses
2,680.22
3,797.74
2,792.99
2,614.38
2,552.94
2,679.54
2,177.66
Other Expenses
67.22
33.41
49.88
60.56
57.64
39.73
78.58
Total Expenditure (Excl Depreciation)
6,818.61
9,087.17
7,912.97
6,733.74
5,694.71
6,839.11
5,914.43
Operating Profit (PBDIT) excl Other Income
-340.90000000000003
1091.3
1813.8999999999999
225.2
-145.2
1626.6
186.29999999999998
Other Income
738.47
1,163.91
517.77
1,281.93
497.95
522.07
972.45
Operating Profit (PBDIT)
1,142.02
3,010.60
3,050.71
2,132.71
863.86
2,686.48
1,620.88
Interest
57.82
54.54
54.21
53.44
40.55
41.92
34.17
Exceptional Items
-6.22
-216.60
-4.41
-8.81
-1.11
-69.99
-0.69
Gross Profit (PBDT)
3,069.29
5,277.69
5,159.92
3,498.59
3,024.75
4,745.36
3,183.91
Depreciation
744.48
755.42
719.01
625.56
511.09
537.78
462.18
Profit Before Tax
333.50
1,984.03
2,273.07
1,444.90
311.09
2,036.78
1,123.84
Tax
77.00
295.57
409.49
246.77
196.68
323.82
292.54
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
260.42
1,719.30
1,874.51
1,208.84
122.19
1,736.61
828.48
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
260.42
1,719.30
1,874.51
1,208.84
122.19
1,736.61
828.48
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-3.92
-30.84
-10.93
-10.71
-7.79
-23.65
2.82
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
256.50
1,688.46
1,863.58
1,198.14
114.41
1,712.96
831.30
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
35,513.48
40,022.74
44,988.21
36,429.23
33,319.07
34,114.42
30,184.28
Earnings per share (EPS)
6.26
41.3
45.03
29.04
2.94
41.71
19.9
Diluted Earnings per share
6.26
41.3
45.03
29.04
2.94
41.71
19.9
Operating Profit Margin (Excl OI)
-5.26%
10.72%
18.65%
3.24%
-2.62%
19.21%
3.05%
Gross Profit Margin
16.64%
26.91%
30.76%
29.75%
14.82%
30.41%
26.0%
PAT Margin
4.02%
16.89%
19.27%
17.37%
2.2%
20.51%
13.58%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2025 is 16.73% vs -4.40% in Jun 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2025 is 124.21% vs -91.72% in Jun 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2025 is 10.28% vs -77.92% in Jun 2024

stock-summary

Interest

YoY Growth in quarter ended Jun 2025 is 42.36% vs 10.03% in Jun 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024

Compare Quarterly Results Of Shin Nippon Biomedical Laboratories, Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
6,477.68
26,186.00
-19,708.32
-75.26%
Other Operating Income
0.00
0.00
0.00
Total Operating income
6,477.68
26,186.00
-19,708.32
-75.26%
Raw Material Cost
3,408.39
20,645.00
-17,236.61
-83.49%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
57.82
3.00
54.82
1,827.33%
Selling and Distribution Expenses
2,680.22
5,727.00
-3,046.78
-53.20%
Other Expenses
67.22
-0.30
67.52
22,506.67%
Total Expenditure (Excl Depreciation)
6,818.61
26,372.00
-19,553.39
-74.14%
Operating Profit (PBDIT) excl Other Income
-340.94
-186.00
-154.94
-83.30%
Other Income
738.47
757.00
-18.53
-2.45%
Operating Profit (PBDIT)
1,142.02
1,393.00
-250.98
-18.02%
Interest
57.82
3.00
54.82
1,827.33%
Exceptional Items
-6.22
-120.00
113.78
94.82%
Gross Profit (PBDT)
3,069.29
5,541.00
-2,471.71
-44.61%
Depreciation
744.48
822.00
-77.52
-9.43%
Profit Before Tax
333.50
449.00
-115.50
-25.72%
Tax
77.00
291.00
-214.00
-73.54%
Provisions and contingencies
0
0
0.00
Profit After Tax
260.42
106.00
154.42
145.68%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
260.42
106.00
154.42
145.68%
Share in Profit of Associates
0
0
0.00
Minority Interest
-3.92
52.00
-55.92
-107.54%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
256.50
158.00
98.50
62.34%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
35,513.48
70,340.00
-34,826.52
-49.51%
Earnings per share (EPS)
6.26
6.73
-0.47
-6.98%
Diluted Earnings per share
6.26
6.73
-0.47
-6.98%
Operating Profit Margin (Excl OI)
-5.26%
-0.71%
0.00
-4.55%
Gross Profit Margin
16.64%
4.85%
0.00
11.79%
PAT Margin
4.02%
0.40%
0.00
3.62%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 647.77 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -36.36% vs 4.64% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 16.73% vs -4.40% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 25.65 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -84.81% vs -9.40% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 124.21% vs -91.72% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 40.35 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -78.15% vs -27.09% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 10.28% vs -77.92% in Jun 2024

Quarterly - Interest
Interest 5.78 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 6.06% vs 0.55% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 42.36% vs 10.03% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -5.26%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024